The Lancet (2023) 8
Below 1 mg is supported by acute Phase 1 readings in lean Asian participants and real-world reports, but not by a chronic dosing trial
Retatrutide Dosage Protocols from Clinical Trials Phase 2 clinical trials published in The New England Journal of Medicine in 2023 established the foundational retatrutide dosage framework [6]: Standard Retatrutide Dosing Schedule: 4 mg weekly Lower effective dose with moderate efficacy 8 mg weekly Mid-range dose with enhanced metabolic effects 12 mg weekly Maximum studied dose achieving 24.2% mean weight reduction The 12 mg dose demonstrated the most significant metabolic effects but also carried the highest incidence of gastrointestinal adverse events, with nausea reported in 60-80% of participants [7]
Journal of Biology and Today's World
Over years, constant frowning or squinting leaves deep creases in the forehead and, unfortunately, it can cause you to look constantly angry or tired
As we can see in the images below side effects tended to be a little higher than injectable medications and I have a hypothesis as to why (more on that in a minute.) But regardless of whether you look at ATTAIN 1 or 2, the rate of diarrhea, constipation, nausea and vomiting were all similar